These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4927406)

  • 1. Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    Appl Microbiol; 1971 Feb; 21(2):295-9. PubMed ID: 4927406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological studies of Clostridium botulinum type E and related organisms. II. Serology of spores.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    J Bacteriol; 1969 May; 98(2):407-14. PubMed ID: 4891254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patterns in the formation of proteolytic enzymes by different strains of C1. botulinum type F].
    Egorova EN; Ispolatovskaia MV; Levdikova GA; Chulkova IF
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):125-9. PubMed ID: 325959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive inhibition between different Clostridium botulinum types and strains.
    Eklund MW; Poysky FT; Peterson ME; Paranjpye RN; Pelroy GA
    J Food Prot; 2004 Dec; 67(12):2682-7. PubMed ID: 15633672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic mutants obtained from Clostridium botulinum type E.
    Nakane A; Iida H
    Appl Environ Microbiol; 1977 Jul; 34(1):99-101. PubMed ID: 329766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Clostridium botulinum, Clostridium argentinense, and related organisms by cellular fatty acid analysis.
    Ghanem FM; Ridpath AC; Moore WE; Moore LV
    J Clin Microbiol; 1991 Jun; 29(6):1114-24. PubMed ID: 1864927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antigenic structure of Cl. botulinum types E and F].
    Bulatova TI; Perova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Apr; 47(4):28-32. PubMed ID: 4920529
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunofluorescent study of the spore antigens of proteolytic strains of Clostridium botulinum.
    Princewill TJ
    J Hyg (Lond); 1979 Aug; 83(1):1-9. PubMed ID: 379206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological studies of Clostridium botulinum type E and related organisms.
    Lynt RK; Solomon HM; Kautter DA; Lilly T
    J Bacteriol; 1967 Jan; 93(1):27-35. PubMed ID: 5335894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Clostridium botulinum by strains of Clostridium perfringens isolated from soil.
    Smith LD
    Appl Microbiol; 1975 Aug; 30(2):319-23. PubMed ID: 169734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of Clostridium botulinum type B and E progenitor toxins to some clostridial sulfhydryl-dependent proteases.
    Oishi I; Okada T; Sakaguchi G
    Jpn J Med Sci Biol; 1975 Jun; 28(3):157-64. PubMed ID: 1104932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and differential medium for detecting Clostridium botulinum.
    Silas JC; Carpenter JA; Hamdy MK; Harrison MA
    Appl Environ Microbiol; 1985 Oct; 50(4):1110-1. PubMed ID: 2867740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW; Poysky FT
    Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of the common antigens of Clostridium botulinum, C. sporogenes and C. novyi by an enzyme-linked immunosorbent assay and electroblot transfer.
    Poxton IR
    J Gen Microbiol; 1984 Apr; 130(4):975-81. PubMed ID: 6376703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cl. botulinum type F toxin formation on non-meat nutrient media].
    Perova EV; Bulatova TI; Lukina LS
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Sep; 47(9):46-51. PubMed ID: 4932823
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth and toxin production of Clostridium botulinum types E, nonproteolytic B, and F in nonirradiated and irradiated fisheries products in the temperature range of 36 degrees to 72 degrees F. TID-24881.
    Eklund MW; Poysky FT; Wieler DI
    TID Rep; 1966 Jan; ():1-86. PubMed ID: 4905224
    [No Abstract]   [Full Text] [Related]  

  • 18. Outgrowth and toxin production of nonproteolytic type B Clostridium botulinum at 3.3 to 5.6 C.
    Eklund MW; Wieler DI; Poysky FT
    J Bacteriol; 1967 Apr; 93(4):1461-2. PubMed ID: 5340312
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of Clostridium botulinum type F isolated from the Pacific Coast of the United States.
    Eklund MW; Poysky FT; Wieler DI
    Appl Microbiol; 1967 Nov; 15(6):1316-23. PubMed ID: 4865980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of proteolytic Clostridium botulinum strains, determined by a pulsed-field gel electrophoresis approach.
    Nevas M; Lindström M; Hielm S; Björkroth KJ; Peck MW; Korkeala H
    Appl Environ Microbiol; 2005 Mar; 71(3):1311-7. PubMed ID: 15746333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.